THE SUBJECT-BY-FORMULATION INTERACTION AS A CRITERION OF INTERCHANGEABILITY OF DRUGS

被引：46

作者：

EKBOHM, G ^{[1
]}

MELANDER, H ^{[1
]}

机构：

[1] NATL BOARD HLTH & WELF,DEPT DRUGS,S-75125 UPPSALA,SWEDEN

来源：

BIOMETRICS | 1989年 / 45卷 / 04期

关键词：

D O I：

10.2307/2531776

中图分类号：

Q [生物科学];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

引用

收藏

页码：1249 / 1254

页数：6

相关论文

共 16 条

[1] ALBERT KS, 1980, DRUG ABSORPTION DISP, P87
[2] ARMITAGE P, 1982, STATISTICIAN, V31, P119
[3] BRONLEE KA, 1965, STATISTICAL THEORY M
[4] CROSSOVER EXPERIMENT FOR CLINICAL-TRIALS
BROWN, BW
[J]. BIOMETRICS, 1980, 36 (01) : 69 - 79
[5] Cox DR., 1958, PLANNING EXPT
[6] 3-PERIOD CROSSOVER DESIGNS FOR 2 TREATMENTS
EBBUTT, AF
[J]. BIOMETRICS, 1984, 40 (01) : 219 - 224
[7] GRAHNEN A, 1984, EUR J CLIN PHARMACOL, V27, P595, DOI 10.1007/BF00556898
[8] 2-PERIOD CHANGE-OVER DESIGN AND ITS USE IN CLINICAL TRIALS
GRIZZLE, JE
[J]. BIOMETRICS, 1965, 21 (02) : 467 - &
[9] STATISTICAL SIMULATION STUDY OF NEW PROPOSED UNIFORMITY REQUIREMENT FOR BIOEQUIVALENCY STUDIES
HAYNES, JD
[J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1981, 70 (06) : 673 - 675
[10] 2-PERIOD CROSSOVER CLINICAL-TRIAL
HILLS, M
ARMITAGE, P
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 8 (01) : 7 - 20